Develops novel treprostinil prodrugs for PAH, delivering once-daily treatment through a transdermal patch for improved patient outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Corsair Pharma Management Team
Investors
H&Q Healthcare Investors
Junson Capital
Midas Capital
Plaisance Capital Management
Primavera Capital
Corsair Pharma Valuations & Financials
View real-time NPM data on Corsair Pharma stock including daily Corsair Pharma stock price estimates, valuation history, and historical share price information. Access Corsair Pharma financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Corsair Pharma pricing across six independent market signals. Looking for private company due diligence data sources on Corsair Pharma? Get in touch to learn more.
Similar Companies
like Corsair Pharma
MilkMate
Healthcare & Life Sciences
Simplifies breast pumping with integrated equipment, supplies, and managed support services.
Nomad Health
Healthcare & Life Sciences
Provides an AI platform that automates customer service interactions and resolves requests across channels to improve efficiency and support quality.
ReliefBand Technologies
Healthcare & Life Sciences
Builds neuromodulation wristbands to treat physical symptoms of nausea without pharmaceuticals.
Maximum Fidelity Surgical Simulations
Healthcare & Life Sciences
Engineers automated surgical simulation platforms to provide realistic physiological feedback during clinical training.
Curebase
Healthcare & Life Sciences
Enables decentralized clinical trials with all-in-one software, empowering patient choice and supporting virtual and traditional site operations.
Dacadoo
Healthcare & Life Sciences
Digital health platform using AI and behavioral science to improve wellness outcomes through personalized engagement and gamification.
Min Doktor
Healthcare & Life Sciences
Digital healthcare platform providing 24/7 online medical consultations, prescriptions and referrals through licensed healthcare professionals.
Proniras
Healthcare & Life Sciences
Develops novel small-molecule therapeutics for substance use and specialty CNS disorders targeting unmet medical needs.
InterVenn
Healthcare & Life Sciences
Delivers artificial intelligence-driven glycoproteomic analysis to accelerate early disease detection and clinical biomarker discovery for personalized medicine.
FAQ
We have answers
Corsair Pharma stock does not trade on public stock exchanges. Corsair Pharma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Corsair Pharma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Corsair Pharma Stock does not trade on public stock exchanges. In order to sell Corsair Pharma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Corsair Pharma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Corsair Pharma share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Corsair Pharma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Corsair Pharma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Corsair Pharma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Corsair Pharma is a private company and has not had an IPO. There is currently no Corsair Pharma IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Corsair Pharma IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
